338 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34978526 | Crocin ameliorates atherosclerosis by promoting the reverse cholesterol transport and inhibiting the foam cell formation via regulating PPARγ/LXR-α. | 2022 Jan | 1 |
2 | 34981658 | Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma. | 2022 May | 2 |
3 | 35150895 | Enterocyte-specific ATGL overexpression affects intestinal and systemic cholesterol homeostasis. | 2022 Apr | 1 |
4 | 35219337 | LXR agonist improves peripheral neuropathy and modifies PNS immune cells in aged mice. | 2022 Feb 26 | 2 |
5 | 35417135 | Antihyperlipidemic Activity of Gut-Restricted LXR Inverse Agonists. | 2022 May 20 | 3 |
6 | 35477277 | Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis. | 2022 Jun | 2 |
7 | 32681027 | Liver X receptor regulates Th17 and RORγt+ Treg cells by distinct mechanisms. | 2021 Mar | 2 |
8 | 32725442 | PCSK9Qβ-003 Vaccine Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice. | 2021 Feb | 1 |
9 | 33050984 | Combined application of rapamycin and atorvastatin improves lipid metabolism in apolipoprotein E-deficient mice with chronic kidney disease. | 2021 Mar | 1 |
10 | 33165140 | Astragalin Retards Atherosclerosis by Promoting Cholesterol Efflux and Inhibiting the Inflammatory Response via Upregulating ABCA1 and ABCG1 Expression in Macrophages. | 2021 Feb 1 | 1 |
11 | 33188828 | Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transport. | 2021 Jan 10 | 2 |
12 | 33200264 | Liver X Receptor α in Sciatic Nerve Exerts an Alleviating Effect on Neuropathic Pain Behaviors Induced by Crush Injury. | 2021 Feb | 2 |
13 | 33305467 | The roles of liver X receptor α in inflammation and inflammation-associated diseases. | 2021 Jul | 4 |
14 | 33619376 | Diet-dependent regulation of TGFβ impairs reparative innate immune responses after demyelination. | 2021 Feb | 4 |
15 | 33666411 | Liver X Receptor Activation with an Intranasal Polymer Therapeutic Prevents Cognitive Decline without Altering Lipid Levels. | 2021 Mar 23 | 1 |
16 | 33692340 | CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p/LXRα pathway. | 2021 Mar 10 | 2 |
17 | 33770194 | Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction. | 2021 Jul | 2 |
18 | 33945906 | IL-2Rβγ signalling in lymphocytes promotes systemic inflammation and reduces plasma cholesterol in atherosclerotic mice. | 2021 Jun | 1 |
19 | 34251816 | LXR-Mediated Regulation of Marine-Derived Piericidins Aggravates High-Cholesterol Diet-Induced Cholesterol Metabolism Disorder in Mice. | 2021 Jul 22 | 3 |
20 | 34281217 | Muricholic Acids Promote Resistance to Hypercholesterolemia in Cholesterol-Fed Mice. | 2021 Jul 2 | 1 |
21 | 34416392 | Hepatic lysosomal acid lipase drives the autophagy-lysosomal response and alleviates cholesterol metabolic disorder in ApoE deficient mice. | 2021 Dec | 2 |
22 | 34481107 | Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner. | 2021 Nov | 2 |
23 | 34485530 | Morroniside Promotes PGC-1α-Mediated Cholesterol Efflux in Sodium Palmitate or High Glucose-Induced Mouse Renal Tubular Epithelial Cells. | 2021 | 1 |
24 | 34564147 | Saringosterol from Sargassum fusiforme Modulates Cholesterol Metabolism and Alleviates Atherosclerosis in ApoE-Deficient Mice. | 2021 Aug 26 | 3 |
25 | 34564456 | Combined LXR and RXR Agonist Therapy Increases ABCA1 Protein Expression and Enhances ApoAI-Mediated Cholesterol Efflux in Cultured Endothelial Cells. | 2021 Sep 18 | 1 |
26 | 34568800 | Hepatocyte activity of the cholesterol sensor smoothened regulates cholesterol and bile acid homeostasis in mice. | 2021 Sep 24 | 2 |
27 | 34686657 | Smooth muscle 22 alpha protein inhibits VSMC foam cell formation by supporting normal LXRα signaling, ameliorating atherosclerosis. | 2021 Oct 22 | 1 |
28 | 34753029 | Qing-Xue-Xiao-Zhi formula attenuates atherosclerosis by inhibiting macrophage lipid accumulation and inflammatory response via TLR4/MyD88/NF-κB pathway regulation. | 2021 Dec | 2 |
29 | 34831289 | Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina. | 2021 Nov 7 | 1 |
30 | 34926792 | Self-Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche. | 2021 Sep | 2 |
31 | 35082691 | Expressing the Human Cholesteryl Ester Transfer Protein Minigene Improves Diet-Induced Fatty Liver and Insulin Resistance in Female Mice. | 2021 | 1 |
32 | 31602646 | Activation of liver X receptor promotes hippocampal neurogenesis and improves long-term cognitive function recovery in acute cerebral ischemia-reperfusion mice. | 2020 Jul | 1 |
33 | 31678621 | Angiopoietin-1 aggravates atherosclerosis by inhibiting cholesterol efflux and promoting inflammatory response. | 2020 Feb | 1 |
34 | 31759199 | Stigmasterol stimulates transintestinal cholesterol excretion independent of liver X receptor activation in the small intestine. | 2020 Feb | 2 |
35 | 31785104 | Insights From Liver-Humanized Mice on Cholesterol Lipoprotein Metabolism and LXR-Agonist Pharmacodynamics in Humans. | 2020 Aug | 1 |
36 | 31845693 | Selenium alleviates lipopolysaccharide-induced endometritis via regulating the recruitment of TLR4 into lipid rafts in mice. | 2020 Jan 29 | 1 |
37 | 31980500 | Differential Role of Liver X Receptor (LXR) α and LXRβ in the Regulation of UDP-Glucuronosyltransferase 1A1 in Humanized UGT1 Mice. | 2020 Apr | 1 |
38 | 32037099 | Dysregulation of LXR responsive genes contribute to ichthyosis in trichothiodystrophy. | 2020 Mar | 2 |
39 | 32329226 | Complement Receptor Targeted Liposomes Encapsulating the Liver X Receptor Agonist GW3965 Accumulate in and Stabilize Atherosclerotic Plaques. | 2020 May | 2 |
40 | 32414201 | LXRα Regulates ChREBPα Transactivity in a Target Gene-Specific Manner through an Agonist-Modulated LBD-LID Interaction. | 2020 May 13 | 2 |
41 | 32598492 | Luteolin improves hypercholesterolemia and glucose intolerance through LXRα-dependent pathway in diet-induced obese mice. | 2020 Sep | 1 |
42 | 32641586 | Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes. | 2020 Jul 9 | 2 |
43 | 32661772 | NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists. | 2020 Oct | 7 |
44 | 32736671 | Macrophage Lxrα reduces atherosclerosis in Ldlr-/- mice independent of Arl7 transactivation. | 2020 Aug 27 | 4 |
45 | 32779151 | Setosphapyrone C and D accelerate macrophages cholesterol efflux by promoting LXRα/ABCA1 pathway. | 2020 Aug | 1 |
46 | 33050202 | The Crucial Role of Xanthine Oxidase in CKD Progression Associated with Hypercholesterolemia. | 2020 Oct 9 | 2 |
47 | 33098723 | HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation. | 2020 Dec | 2 |
48 | 33190106 | Regulation of intestinal LDLR by the LXR-IDOL axis. | 2020 Dec | 3 |
49 | 33292517 | Iron accumulation in macrophages promotes the formation of foam cells and development of atherosclerosis. | 2020 Nov 26 | 1 |
50 | 33390931 | Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice. | 2020 | 2 |